Rare transthyretin Mutation p.Ala101Val Unmasks Late-Onset Cardiac Phenotype with Reduced Scintigraphic Sensitivity in Belarusian Cohort
en-GBde-DEes-ESfr-FR

Rare transthyretin Mutation p.Ala101Val Unmasks Late-Onset Cardiac Phenotype with Reduced Scintigraphic Sensitivity in Belarusian Cohort

18/11/2026 HEP Journals

ATTRv is a rare autosomal dominant disorder caused by transthyretin (TTR) mutations. The p.Ala101Val variant has been reported but its phenotype is not fully defined. Characterizing variant‑specific features guides diagnosis.
In this study, researchers in Minsk studied five unrelated probands (aged 64 to 74) with heterozygous TTR c.302C>T. Comprehensive cardiac imaging, electrophysiology, and neurological exams were performed. Four had cardiomyopathy, while one had arrhythmic events without overt cardiomyopathy. All had neuropathy, two with carpal tunnel syndrome. Bone scintigraphy showed Grade 1 or 2 uptake. One required a pacemaker, later resynchronization. Two developed heart failure and died within one year.
These findings confirm p.Ala101Val causes late‑onset ATTRv with cardiac, arrhythmic, and neurologic features. The reduced scintigraphic sensitivity, also seen in Polish patients, is a pitfall: low uptake does not exclude ATTR. Clinicians should suspect ATTR and order genetic testing when red flags appear, even with equivocal scintigraphy. Genotype‑informed algorithms are needed where this variant may be underrecognized.
The work titled “Clinical phenotypes linked to the p.Ala101Val mutation in the TTR gene in Belarusian patients with transthyretin amyloidosis”, was published on Cardiac Research (accepted on May. 13, 2026).
DOI:10.1097/re9.0000000000000018
18/11/2026 HEP Journals
Regions: Asia, China, Europe, Russian Federation
Keywords: Science, Life Sciences

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Témoignages

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Nous travaillons en étroite collaboration avec...


  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by DNN Corp Terms Of Use Privacy Statement